CYTEK BIOSCIENCES, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.73 USD | +5.14% |
|
+1.96% | -37.17% |
| 06-12 | Cytek Biosciences to Seek M&A | CI |
| 06-12 | Transcript : Cytek Biosciences, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 09:20 AM |
Presenter SpeechMatthew Sykes (Analysts)Great. Good morning, everyone. My name is Matt Sykes, ...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Cytek Biosciences, Inc. is a cell analysis solutions company. The Company is advancing the cell analysis tools by delivering high-resolution, high-content and high-sensitivity cell analysis utilizing its Full Spectrum Profiling (FSP) technology. Its FSP platform includes its core instruments, the Cytek Aurora and Northern Lights systems; its cell sorter, the Cytek Aurora CS; the Cytek Orion reagent cocktail preparation system; the flow cytometer and imaging products under the Amnis and Guava brands; and reagents, software and services to provide a comprehensive and integrated suite of solutions for its customers. Its Cytek Aurora and Cytek Northern Lights systems are flow cytometers that deliver high-resolution, high-content, and high-sensitivity cell analysis. Its Cytek Aurora CS is a cell sorter that leverages the detection and sensitivity capabilities of its FSP technology to isolate living cell populations from lower to higher complexity panels beyond 40 biomarkers.
Calendar
2024-08-06
- Q2 2024 Earnings Release (Projected)
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
D+
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
6
Last Close Price
5.73
USD
Average target price
9.5
USD
Spread / Average Target
+65.79%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -37.17% | 752M | |
| +6.37% | 216B | |
| +10.21% | 189B | |
| +28.22% | 153B | |
| +34.42% | 114B | |
| +0.80% | 63.2B | |
| +19.21% | 54.78B | |
| +0.13% | 48.47B | |
| -4.16% | 38.88B | |
| +2.39% | 36.14B |
- Stock Market
- Equities
- CTKB Stock
- News Cytek Biosciences, Inc.
- Transcript : Cytek Biosciences, Inc. Presents at Goldman Sachs 45th Annual Global Healthcare Conference, Jun-12-2024 09
